Textextraktion: pypdf | Seiten: 36
1 Local Division Munich UPC_CFI_233/2023 Decision on the merits of the Court of First Instance of the Unified Patent Court delivered on July 31st 2024 2 CLAIMANT DexCom, Inc. , represented by its CEO Kevin Sayer , 6340 Sequence Drive, 92121 - San Diego, CA – USA, Represented by: Quinn Emanuel Urquhart & Sullivan, LLP, Hermann -Sack-Straße 3, 80331 Munich DEFENDANTS 1. Abbott Laboratories, represented by its board of directors which is represented by the CEO Robert Ford, 100 Abbott Park Road, Abbott Park, Illinois 60064-6400, USA 2. Abbott Diabetes Care Inc. , represented by its president Jared Watkin , 1360 South Loop Road, Alameda, California 94502, USA 3. Abbott GmbH, represented by its managing directors Christian Grapow, Robert Funck, and Varlas Konstantinos , Max-Planck-Ring 2, 65205 ...